A comprehensive catalog of CpG islands methylated in human lung adenocarcinomas for the identification of tumor suppressor genes.
CpG island methylation is an important mechanism in gene silencing and is a key epigenetic event in cancer development. As yet, the number and identities of the genes that are inactivated in cancer cells has not been determined. In order to address this issue, we have performed a comprehensive isolation of CpG islands that are methylated in human lung adenocarcinomas. We have isolated approximately 200 CpG islands that are methylated in tumor DNA including those of known tumor-associated genes such as the HOXA5 gene. As the library contains the CpG islands of a number of known tumor suppressor genes it is highly likely that additional, previously unidentified tumor suppressor genes, will be present. On average, 1-2% of CpG islands were methylated specifically in tumors although this figure differed greatly between patients. This study provides an important resource in the search for genes inactivated in tumors and for the investigation of epigenetic dysregulation of gene expression by CpG island methylation.
Shiraishi
Masahiko
M
DNA Methylation and Genome Function Project, National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan. mshirais@ncc.go.jp
Sekiguchi
Azumi
A
Terry
Michael J
MJ
Oates
Adam J
AJ
Miyamoto
Yuji
Y
Chuu
Ying H
YH
Munakata
Miyo
M
Sekiya
Takao
T
D000230:Adenocarcinoma / Q000235:genetics*; D000368:Aged; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation; D016147:Genes, Tumor Suppressor; D015698:Genomic Library; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014158:Transcription, Genetic